US appeals court rules that rival medtech company Colibri Heart Valve could not assert infringement under doctrine of equivalents ...

For Dr. Carolyn Kaloostian, the American Heart Association’s mission is deeply personal. While in medical school, she tragically lost her mother to cardiac arrest. Years later, she faced a similar ...

Top Brand LLC v. Cozy Comfort Company LLC, Appeal No. 2024-2191 (Fed. Cir. July 17, 2025) In this week’s Case of the Week, ...

The prosthetic heart valve market is expected to reach USD 15,294.6 million by 2025 and grow at a compound annual growth rate (CAGR) of 7.5% to reach USD 31,522.6 million by 2035.  The prosthetic ...

NewYork-Presbyterian researchers have developed a deep learning model that increases doctors' abilities to diagnose ...

The Federal Circuit overturned a $106 Million verdict against Medtronic, ruling that Colibri was barred from claiming patent infringement.

The new AI screening tool EchoNext outperforms cardiologists at detecting structural heart problems by 20 percent.

The U.S. Court of Appeals for the Federal Circuit has overturned a more than $125 million judgment against Medtronic’s ...

A U.S. appeals court on Friday overturned a jury's verdict that medical device maker Medtronic owes competitor Colibri $106.5 ...

Artificial intelligence (AI) can turn a common doctor’s office test into a screening tool for detecting structural problems ...

A newly developed artificial intelligence (AI) tool, that uses data from the low-cost electrocardiogram (ECG), may be more ...

The global transcatheter heart valve replacement (TAVR) market is estimated to be valued at USD 8.18 billion in 2025 and is projected to reach USD 32.82 billion by 2035, registering a compound annual ...